EZZELDIN M Ibrahim - Ego JUNE 2013 (1).doc · Web viewProf. Ezzeldin M Ibrahim Senior Consultant Oncologist Director, Oncology Center of Excellence Chairman, Department of Internal

Prof. Ezzeldin M Ibrahim

Senior Consultant OncologistDirector, Oncology Center of Excellence

Chairman, Department of Internal MedicineExecutive Director, Research Center

International Medical Center

June 2013

June 2013 Ezzeldin M Ibrahim

Table of Contents

PERSONAL DATA...........................................................................3EDUCATION AND QUALIFICATIONS.................................................4MPLOYMENT RECORD....................................................................4EDITORIAL BOARDS MEMBERSHIP..................................................6MEMBERSHIP IN PROFESSIONAL ORGANIZATIONS & SOCIETIES.......6PRIOR ADMINISTRATIVE APPOINTMENTS........................................7CONFERENCES, SEMINARS AND SCIENTIFIC MEETINGS ATTENDED...9SPECIAL SKILLS...........................................................................13PAPERS PUBLISHED IN CONFERENCES’ PROCEEDINGS...................14EDITED BOOKS & CHAPTERS IN BOOKS.........................................21PUBLICATIONS............................................................................23

2


PERSONAL DATA

Surname: IbrahimFirst Name: Ezzeldin Middle Names: Moustafa Ali

Nationality: SaudiMarital Status: Married and have 4 childrenPresent Position: Director, Oncology Center of Excellence

Senior Consultant, OncologistChairman, Department of Internal MedicineExecutive Director, Research CenterInternational Medical Center

Saudi Arabia Address: International Medical CenterOncology Center of ExcellencePO Box 2172, Jeddah 21451Saudi ArabiaTel. +9662-6509000 Ext. 9877Mobile +9665-0582-5953Fax +9662-6509141 or 6509001

USA Address: 8676 Kenwood RoadCincinnati, OH 45242, USATel. +1-513-936-8244Mobile +1-513-702-2233

E-mail: [email protected]

3

mailto:[email protected]


EDUCATION AND QUALIFICATIONS

1961 Primary School Diploma, Egypt.1964 Secondary School Diploma, Egypt.1967 High School Diploma, Egypt (90%).1973 MB, BCh (Honors), Faculty of Medicine, Cairo University, Egypt.1978 MRCPI1981 Oncology Fellowship, University of British Columbia,

Vancouver, Canada1989 FRCP, Ireland.1998 Fellow of the American College of Physicians2005 MSc in Medical Informatics, University of Bath, Bath, UK

MPLOYMENT RECORD2012-presentChairman, Department of Internal MedicineInternational Medical Center (Jeddah)2010-presentDirector, Oncology Center of ExcellenceSenior Consultant, OncologyInternational Medical Center (Jeddah)2010-presentExecutive Director, Research CenterInternational Medical Center (Jeddah)2009-2010Senior Consultant, Department of OncologyKing Faisal Specialist Hospital & Research Center (Jeddah)2007-2009Executive Director of the Research Center, King Faisal Specialist Hospital & Research Center (Jeddah)2007-2009Chairman, Department of OncologyKing Faisal Specialist Hospital & Research Center (Jeddah)2005-2010Chairman, MyCare Task Force (Pharmacy Clinical Information and Billing

System)2006-2007Chief Medical Officer, King Faisal Specialist Hospital & Research Center

(Jeddah)2003-2006Executive Director of the Research Center, King Faisal Specialist Hospital & Research Center (Jeddah)2000-2006Chairman, Department of OncologyKing Faisal Specialist Hospital & Research Center (Jeddah)2000-2010Senior Consultant Oncologist, King Faisal Specialist Hospital & Reseach Center

(Jeddah)

4


1998-2000Consultant Oncologist, King Faisal Specialist Hospital & Reseach Center

(Riyadh)Medical Director, Oncology Data Unit1992 - 1998Professor of Medicine, Department of Medicine, College of Medicine and

MedicalSciences, King Faisal University, Saudi Arabia.1985 - 1992:Associate Professor of Medicine, Department of Medicine, College of Medicineand Medical Sciences, King Faisal University, Saudi Arabia.1981- 1985:Assistant Professor of Medicine, Department of Medicine, College of Medicineand Medical Sciences, King Faisal University, Saudi Arabia.1981 - 1998:Consultant Physician and Oncologist, King Fahd Hospital of King Faisal

University, Saudi Arabia.1979-l981:Senior and Chief Resident (R5 & R6), Department of Medical Oncology, CancerControl Agency of the University of British Columbia, Vancouver, Canada.1978-1979:Registrar in Medicine, Department of Internal Medicine, Preston Hospital, North Tyneside Health Authority, North Shields, United Kingdom.1976-1978:Registrar in Intensive Medicine and Nephrology, Professorial Unit, Department of Internal Medicine, Newcastle University, Newcastle, United

Kingdom.1975-1976:Registrar in Internal Medicine, Khartoum Teaching Hospital, Sudan.1974-1975:Internship, Khartoum Teaching Hospital, Sudan.

5


EDITORIAL BOARDS MEMBERSHIP

1. Associate Editor: Medical Oncology2. Statistical Consultant: International Journal of Health Geographics3. Editorial Board Member: Hematology/Oncology and Stem Cell Therapy4. Editorial Board Member: International Word of Meta-analysis5. Editorial Board Member: Journal of Clinical Research and Governance

MEMBERSHIP IN PROFESSIONAL ORGANIZATIONS & SOCIETIES

1. Fellow of the American College of Physicians2. Fellow of the Royal College of Physicians of Ireland.3. Member of the Royal College of Physicians of Ireland.4. Member of the American Society of Clinical Oncology.5. Member of the International Society of Preventive Oncology.6. Member of the European Society of Medical Oncology.7. Member of the European Society of Surgical Oncology.

6

http://index.sciencepub.se/ojs/index.php/JCRG/index

http://www.hemoncstem.net/

http://www.ij-healthgeographics.com/

http://www.springer.com/medicine/oncology/journal/12032?detailsPage=editorialBoard


PRIOR ADMINISTRATIVE APPOINTMENTSKFSH&RC - RIYADH

1. Medical Director of Oncology Data Unit (1998 – 2000).2. Developed and supervised the Saudi Career Developing program for the

Tumor Registrars (1998).3. Coordinator of Breast Cancer Program (1998 – 2000).4. Chairman, Research Committee (1998 – 2000).5. Department Representative, Y2K Committee (1999).

KFSH&RC - Jeddah1. Executive Director of the Research Center, King Faisal Specialist Hospital

& Research Center (Jeddah, 2007-Present)2. Chairman, Department of Oncology King Faisal Specialist Hospital &

Research Center (Jeddah, 2007-Present)3. Chairman, MyCare Task Force for the Pharmacy Clinical Information and

Billing System (2005-Present)4. Chief Medical Officer, King Faisal Specialist Hospital & Research Center

(Jeddah, 2006-2007)5. Chairman of the International Oncology Update Conference (2007)6. Executive Director of the Research Center, King Faisal Specialist Hospital

& Research Center (Jeddah, 2003-2006)7. Chairman, Department of Oncology (2000 – 2006)8. Chairman, Evidence-Based Medicine (GUIDE-ME, 2001 – present).9. Chairman of the Organizing Committee of the Medical Decision Support

Workshop10.Member, Organizing Committee of the community service activity:

Cancer, numbers and facts (September, 2001).11.Chairman, organizing committee of Embryonic Stem Cell Research

(2001).12.Member, the organizing committee of Chemotherapy Conference (2000).13.Director of the Directorship of Advanced Research and Technology

Supports (2001 – present).14.Chairman of the Organizing Committee: Research Methodology

Workshop (2000).15.Member, International Oncology Symposium organizing committee

(2001).16.Member, International BMT Conference organizing committee (2001).17.Chairman, Scientific Committee for the Breast Diseases Symposium

(2002).18.Chairman, International Integrated Medicine Symposium (2002).19.Chairman, International Supportive Care in Oncology Conference (2003).20.Acting Executive Director of the Research Center, King Faisal Specialist

Hospital & Research Center – Jeddah (2003-present)

King Faisal University1. Member of the Dean’s Advisory Committee [1991 – 1997].2. Chairman of the Curriculum and Medical Education Committee [1994-

1998].

7


3. Vice Dean for Postgraduate Studies [1991-1994].4. Organizer of a workshop on “Medical Education in Clinical Clerkships and

Clinical Postgraduate Programs”.5. Chairman of the Research and Library Committee (College level)

[October 1992-1994].6. Served as an acting chairman of the department of internal medicine on

several occasions and took the department's administrative responsibility during the absence of the chairman [1986-l991].

7. Member of the Quality Assurance Committee (College level) [1987-l989].8. Chairman, Pharmacy and Therapeutic Committee (College level) [1984-

1989].9. Member of the Organization Committee for the Leukemia-Lymphoma

Conference College level) [1983].10.Member of the Forms Committee (College level) [1984 - 1987].11.Member of the Editorial Board for the Proceedings of the Seventh Saudi

Medical Meeting (University level) [1982].12.Member of the Exhibition Committee of the 7th Saudi Medical Meeting

(College level) [1982].13.Member of the Dean's Working Group for Clinical Curriculum (College

level) [1981 - 1982].14.Member of several investigative committees (College level ) [1981 -

1998].15.Member of the Research and Library Committee (College Level) [1990 -

1994].16.Vice Dean for Postgraduate Studies and Medical Specialties (College

Level) [1991 - 1994].17.Coordinator of Internship Training Program (College Level) [1991 -

1994].

Unversity of British Columbia1. Teaching and supervision of junior residents during their rotation in the

Medical Oncology Department of the University of British Columbia [1979 - 1981].

2. Coordination of the Residency Training Program and Postgraduate Activity [1979 - 1981].

8


CONFERENCES, SEMINARS AND SCIENTIFIC MEETINGS ATTENDED

2012 Angiogenesis, Istanbul, Turkey2012 Oncology Update 2012, Jeddah, Saudi Arabia2011 San Antonio Bresat Conference, San Antonio, USA2011 The 5th International Breast Cancer Conference, Paris, France 2010 International Symposium: Recent Update on Cetuximab

(Beirut, Lebanon – Attended as Speaker)2010 International Symposium on New Frontiers in Breast Cancer

(Attended as Speaker)2010 International Conference on New Frontiers in Breast Cancer2010 Best of San Antonio, Riyadh, Saudi Arabia2009 Antonio Breast Conference, San Antonio, USA.2008 Sanofi-Aventis Intercontinental Oncology Meeting, Estorial,

Portugal (Attended as a Member of the International Advisory Board)

2008 Recent Advances in Surgical Practice, Jeddah, Saudi Arabia2007 Family Medicine Update, Jeddah, Saudi Arabia2007 The Forty-Third Meeting of the American Society of Clinical

Oncology, Chicago, Illinois, USA 2007 Writing Biomedical Research Paper, Jeddah, Saudi Arabia2007 Oncology Update, Cairo, Egypt2007 Early Breast Cancer Conference, Jeddah, Saudi Arabia2007 Women Health Update, Jeddah, Saudi Arabia2007 International Oncology Update, Jeddah, Saudi Arabia2006 Interactive Computer Applications on Biostatistics, Jeddah, Saudi

Arabia2006 KACST Ethics in Research, Riyadh, Saudi Arabia2006 International Oncology Symposium, Riyadh, Saudi Arabia2006 Clinical Trials: Ethical Issues, Jeddah, Saudi Arabia2006 Update on Oncology, Cape Town, South Africa2006 Saudi Cancer Society and the Arab Thoracic Association, Jeddah,

Saudi Arabia2006 Writing a Scientific Paper, Jeddah, Saudi Arabia2006 Intoduction to Healthinformatics, Jeddah, Saudi Arabia2005 Bioethics Symposium, Jeddah, Saudi Arabia2005 Biostatistics Course, Jeddah, Saudi Arabia2005 Nursing Workshop, Jeddah, Saudi Arabia2005 Principles of Biomedical Research, Jeddah, Saudi Arabia2004 The Fortieth Meeting of the American Society of Clinical Oncology,

New Orleans, Louisiana, USA2004 Novartis Lead Experts, Boston, USA2004 International Bone Marrow Transplantation Symposium, Jeddah,

Saudi Arabia2004 Lung Cancer Symposium, Jeddah, Saudi Arabia2003 The Thirty-Ninth Meeting of the American Society of Clinical

Oncology, Chicago, Illinois, USA 2003 Update in Breast Cancer, Jeddah, Saudi Arabia

9


2003 Middle East Oncology, Dubai, UAE2003 International Symposium: Supportive Care in Oncology, Jeddah,

Saudi Arabia2002 The Thirty-Eight Meeting of the American Society of Clinical

Oncology, USA2002 Medical Decision Support Workshop, Jeddah, Saudi Arabia 2002 Cancer Update 2002, Riyadh, Saudi Arabia2001 Breast Cancer Symposium, Mekkah, Saudi Arabia2001 The Thirty-Seventh Meeting of the American Society of Clinical

oncology, San Francisco, California, USA.2001 Breast Pathology Conference, KFSH & RC, Jeddah, Saudi Arabia.2001 Update in Hematology, Jeddah, Saudi Arabia2000 The 23rd Annual San Antonio Breast Conference, San Antonio,

Texas USA.2000 The Second Meeting of the Syrian Association of Oncology,

Damascus, Syria2000 The Thirty-Sixth Meeting of the American Society of Clinical

oncology, New Orleans, Louisiana, USA.1999 The 22nd Annual San Antonio Breast Conference, San Antonio,

Texas USA.1999 The Thirty-Fifth Meeting of the American Society of Clinical

oncology, Atlanta, Georgia, USA.1999 The American Society of Clinical Oncology-Panarab Meeting,

Cairo, Egypt.1998 The Thirty-Fourth Meeting of the American Society of Clinical

Oncology, Los Angeles, California, USA.1997 The Annual Meeting of the Pan-Arab Oncology Group, Dubai,

United Arab Emirates1997 The Fifth Meeting of the Saudi Gastroenterology Society, Al-

Khobar, Saudi Arabia1997 The 9th ECCO, Hamburg, Germany1997 The Third Arab-American Conference, Damascus, Syria1996 The European Society of Clinical Oncology, Vienna, Austria1996 The Second Middle East Symposium on Hematopoietic Growth

Factors, Dubai, United Arab Emirates1997 The Third Saudi International Oncology Conference, Riyadh, Saudi

Arabia1996 The First Pan Arab Cancer Conference and the Fourth Egyptian-

French Cancer Congress, Cairo, Egypt 1995 The International Symposium on Computer and Health

Information, Riyadh, Saudi Arabia1995 The 8th ECCO, Paris, France1994 The International Cancer Congress, National Cancer Institute,

Cairo, Egypt.1994 The Saudi International Oncology Conference, King Fahd National

Guard Hospital, Riyadh, Saudi Arabia1994 The 6th International Conference of the Society of Infectious

Diseases, Prague, Czech Republic1994 The Pan-Arab Oncology Workshop, Limasol, Malta

10


1994 Workshop on Medical Education of Clinical Clerkships and Clinical Postgraduate Programs, The Eastern Province, Saudi Arabia

1993 The International Working Group on the Management of Cancer-Related Anemia using r-HuEpo, Lucerne, Switzerland.

1993 The 6th European Conference of Clinical Microbiology and Infectious Diseases, Seville, Spain.

1992 The 7th Meeting of the European Society of Medical Oncology, Lyon, France.

1991 The 5th European Congress of Cardiology, Amsterdam, Netherlands.1991 The International Congress on Breast Cancer, Brussels, Belgium.1991 Quality Assurance in the Kingdom of Saudi Arabia, Qassim, Saudi Arabia.1990 The International Conference on Leukemia, Porto, Portugal.1990 The 4th International Conference on Malignant Lymphoma,

Lugano, Switzerland.1990 The 15th International Cancer Congress (UICC), Hamburg, West

Germany. I also participated in chairing a session about oncology in adults in developing countries.

1989 The 5th European Conference on Cancer and Clinical Oncology, London, United Kingdom.

1989 Acquired Infection and Antibiotics Policies Into the 90's, London, United Kingdom.

1989 The Second Pan-Arab Symposium on Angiotensin Converting Enzyme Inhibitors, Cairo, Egypt.

1989 The 5th European Conference on Clinical Oncology, London, United Kingdom.

1989 Saudi Lymphoma Investigation Group, Riyadh, Saudi Arabia.1988 Infection in Immunocompromised Patients, London, United

Kingdom.1988 The KACST-sponsored Meeting on National Tumor Registry in

Saudi Arabia, Riyadh, Saudi Arabia.1987 Clinical Genetic Conference, Eastern Province, Saudi Arabia.1987 The 3rd International Conference on Malignant Lymphoma,

Lugano, Switzerland.1986 The Annual Meeting of the British Medical Association, Cairo,

Egypt.1986 Breast Cancer and Malignant Lymphoma in Saudi Arabia, Riyadh,

Saudi Arabia.1986 The First Arab-Afro Gastrointestinal Tract Symposium, Cairo,

Egypt.1986 Cancer in Saudi Arabia, Riyadh, Saudi Arabia.1986 The Second Congress of the Mediterranean Society of Therapy,

Istanbul, Turkey.1986 The Fifth Mediterranean Congress of Chemotherapy, Cairo, Egypt.1985 The International Symposium on the Immunobiology of Cancer

and Allied Immune Dysfunction, Copenhagen, Denmark.1985 The Third European Conference on Clinical Oncology, Stockholm,

Sweden.

11


1984 The Sixth International Symposium on Prevention and Detection of Cancer, Vienna, Austria.

1984 The 2nd International Conference on Malignant Lymphoma, Lugano, Switzerland.

1984 King Faisal University - Dana Farber Cancer Institute Workshop on Malignant Lymphoma.

1984 King Faisal University - Harvard Medical School Workshop on Research Methodology, Dammam, Saudi Arabia.

1983 The Eighth Saudi Medical Conference, Riyadh, Saudi Arabia.1983 King Faisal University - World Health Organization Workshop on

Education Planning and Evaluation, Dammam, Saudi Arabia.1983 The International Symposium on Recent Advances in the

Management of Breast Cancer, Istanbul, Turkey.1983 An International Symposium on Recent Advances in Cancer

Chemotherapy, Riyadh, Saudi Arabia.1983 A scientific visit to Dana Farber Cancer Institute, Harvard Medical

School, Boston, USA.1982 A visit to the Oncology-Hematology Department of Geneva

University and to the Interferon production laboratory in Basil, Switzerland.

1982 The Seventh Saudi Medical Meeting, King Faisal University, Dammam, Saudi Arabia.

1981 Conference on Adjuvant Chemotherapy, Tucson, Arizona, USA. 1981 International Conference on Malignant Lymphoma, Stanford

University, San Francisco, USA.1981 The Annual Meeting of the American Association of Cancer

Research and the Annual Meeting of The American Society of Clinical Oncology, Washington, DC, USA.

12


SPECIAL SKILLS

1. Healthcare informatics2. Experience in designing and implementing hospitals computerized

patients information systems. 3. Establishment of research units4. Develop and design decision-support systems5. Utilization of database packages to construct database files for

research data.6. Special interest in medical biostatistics utilizing powerful statistical

software such as SPSS, Statistica, SAS and BMDP. 7. Hospital Evaluation

13


PAPERS PUBLISHED IN CONFERENCES’ PROCEEDINGS

1. Ragaz J, Ibrahim EM, Leahy M, Willan A. Some observations on hormonal therapy of metastatic breast cancer: Aminoglutethiamide with and without tamoxifen. Proceedings of American Society of Clinical Oncology; Washington, DC, USA, Vol. 22, C-452, 448, 1981.

2. Ragaz J, Ibrahim EM, Leahy M, Willan A. A combination of hormones for metastatic breast cancer: Aminoglutethiamide and tamoxifen. Proceedings American Association for Cancer Research; Washington, DC, USA, Vol. 22, 575, 145, 1981.

3. Ragaz J, Leahy M, Ibrahim EM, Spinelli J. Hormonal treatment of metastatic breast cancer: Medical adrenalectomy with Aminoglutethiamide and tamoxifen.Proceedings Clinical and Investigative Medicine; Montreal, Canada, Vol. 2, 23 B, 1981.

4. Ragaz J, Leahy M , Ibrahim EM, Spinelli J, Godolphin WJP. Hormonal treatment of metastatic breast cancer. Proceedings of New Prospective for Breast Cancer;Pennsylvania, USA, P-l 3, 1981.

5. Ragaz J, Ibrahim EM, Leahy M, Spinelli J, Willan AR. Medical adrenalectomy with aminoglutethiamide and tamoxifen for metastatic breast cancer: Effects on response and pituitary hormones. Proceedings American Association for Clinical Research; St. Louis, Missouri, USA, Vol. 23, 571, 145, 1982.

6. Ibrahim EM, Ragaz J, Leahy M. Combination of hormones for the management of metastatic breast cancer: Tamoxifen vs. aminoglutethiamide vs.tamoxifen and aminoglutethiamide. Proceedings of the Seventh Saudi Medical Meeting; Dammam, Saudi Arabia, 31, 1982 (abstract).

7. Ibrahim EM, Ragaz J, Leahy M. Combination of hormones for the management of metastatic breast cancer: Tamoxifen vs. aminoglutethiamide vs.tamoxifen and aminoglutethiamide. Proceedings of the Seventh Saudi Medical Meeting; Dammam, Saudi Arabia, 104-l 09, 1982 (full text).

8. Ibrahim EM, Ragaz J, Leahy M, Spinelli J. Medical adrenalectomy for metastatic breast cancer. Proceedings of the Recent Advances in the Management of Breast Cancer; Istanbul, Turkey, 1983.

9. Ibrahim EM, Mitry N, Al-Idrissi HY, Ibrahim AW. Structure and objectives of the tumor registry of the Eastern province. Proceedings of the Eighth Saudi Medical Conference; Riyadh, Saudi Arabia, 164, 1983.

10. Tamimi TM, Ibrahim EM, Al-Idrissi HY, Ibrahim AW, Mitry NF, Al-Sohamy S, Al-Bar A. Computerized tumor registry of the Eastern Province. Proceedings of the Eighth Saudi Medical Conference; Riyadh, Saudi Arabia (full text) 496-497, 1983.

11. Al-Idrissi HY, Ibrahim EM, Ibrahim AW, Isa AM. Parity in immunology. Proceedings of the Eighth Saudi Medical Conference; Riyadh, Saudi Arabia, 272, 1983.

14


l2. Al-Idrissi HY, Ibrahim EM, Ibrahim AW, Isa AM. Parity in immunology. Proceedings of the Eighth Saudi Medical Conference; Riyadh, Saudi Arabia, (full text) 575-576, 1983.

13. Al-Breiki H, Mitry NF, Khawaja S, Al-Arfaj A, Pirnar T, Ibrahim EM. The value of computerized tomography scan in diagnosis of abdominal masses. Proceedings of the Eight Saudi Medical Conference; Riyadh, Saudi Arabia, 81 , 1983.

14. Mitry N F, Taha S, Pirnar T, Ibrahim EM, Al-Idrissi HY. The value of computerized tomography in urology. Proceedings of the Joint Meeting of the Royal College of Surgeons of Edinburgh; Singapore, 1984.

15. Ibrahim EM, Satti MB, Abdelsatir A, Al-Idrissi HY. The pattern of malignant Iymphoma in the Eastern Province of Saudi Arabia. Proceedings of Second International Conference on Malignant Lymphoma; Lugano, Switzerland 118, 1984.

16. Ibrahim EM, Al-Qurain A, Magbool G, Satti MB, Higazzy M, Al-Qurain A, Satti M, Al-Idrissi HY. Head and neck cancer in Arabia: the role of "Al shamma". Proceedings of the 6th International Symposium on Prevention and Detection of Cancer; Vienna, Austria, (10:103), 432, 1984.

17. Ibrahim EM, Al-Qurain A, Magbool G, Satti M, Higgazy M, Al-Idrissi HY. Head and neck cancer in Arabia: the role of Alshamma. Proceedings of the 3rd European Conference on Clinical Oncology; Stockholm, Sweden, 327, pp 88, 1985.

18. Al-Idrissi HY, Al-Qurain A, Ibrahim EM, Magbool G, Satti MB, Hegazi M. Head and neck cancer in Arabia: the role of "Alqat". Proceedings of the 6th International Symposium on Prevention and Detection of Cancer; Vienna, Austria, (18:102), 431 , 1984.

19. Al-Idrissi HY, Satti MB, Ibrahim EM, Magbool G, Al-Qurain A, Higazzy M. Head and neck cancer in Arabia: the role of Alqat. Proceedings of the 3rd European Conference on Clinical Oncology; Stockholm, Sweden, 328, 1985.

20. Ragaz J, Ibrahim EM, Leahy M, Spinelli J. Aminoglutethiamide (AG) and tamoxifen (T) in combination versus T in metastatic breast cancer: 6 years update. Proceedings of the American Society of Clinical Oncology; USA, Vol. 3, C-465,

21. Ibrahim EM, Al-Idrissi HY, Satti MB, Abdel Satir, Ghani A. Alternating non-cross resistant chemotherapy for advanced breast cancer. Proceedings of the 3rd European Conference on Clinical Oncology; Stockholm, Sweden, 631, 1985.

22. Mitry NF, Ibrahim EM, Yourself A, Taha S, Al-Idrissi HY. The value of CT in staging Hodgkin's and non-Hodgkin's lymphoma and its role in assessment of therapy outcome. Proceedings of the 3rd European Conference on Clinical Oncology; Stockholm, Sweden, 744, 1985.

23. Ibrahim EM, Al-Idrissi HY, Satti MB, Al-Qurain A, Satir A, Ghani, Boukhary H. Combination chemotherapy alone for localized and advanced non-Hodgkin's lymphoma. Proceedings of the 3rd European Conference on Clinical Oncology; Stockholm, Sweden, 755, 1985.

24. Al-Idrissi HY, Ibrahim EM, Al-Qurain A, Satti M, Satir A, Ghani A. Primary hepatocellular carcinoma in the Eastern Province of Saudi Arabia.

15


Proceedings of the 3rd European Conference on Clinical Oncology; Stockholm, Sweden, 395, 1985.

25. Ibrahim EM. The use of systemic chemotherapy in the management of advanced breast cancer. Proceedings of the Symposium, Cancer in Saudi Arabia; pp 39, Riyadh, Saudi Arabia, 1986.

26. Ibrahim EM, Al-Idrissi HY, Ibrahim AW, Dossary 1, Al-Jammaa A, Al-Ethan S. The antiemetic efficacy of high-dose dexamethasone therapy in patients receiving chemotherapy. Proceedings of the international Symposium on the Immunobiology of Cancer, Published in Cancer Detection and Prevention Vol. 8 (516), 14: 096, Copenhagen, Denmark, 1985.

27. Al-Qurain A, Al-Idrissi HY, Ibrahim EM, Satti Mb, Al-Freihi H, Al-Mohaya S, Al-Dossary J, Abdel Hadi M. Esophageal cancer in the Eastern Province of Saudi Arabia: Analysis of therapy and etiology. Proceedings of the international Symposium on the Immunobiology of Cancer, Published in Cancer Detection and Prevention Vol. 8 (516), 14:091, Copenhagen, Denmark, 1985.

28. Al-Idrissi HY, Ibrahim EM, Al-Qurain A, Satti Mb, Al-Dossary J, Abdel Hadi. The pattern of gastrointestinal tract malignancies in Saudi Arabia. Proceedings of the International Symposium on Immunobiology of cancer; Published in Cancer Detection and Prevention Vol. 8 (516), 14: 092, Copenhagen, Denmark, 1985.

29. Al-Nahdy M, Ibrahim EM. Pattern of allergy in a Saudi population. Proceedings of the Annual Meeting of the European Academy of Allergology and Clinical Immunology; F-33, pp 66, Copenhagen, Denmark, 1988.

30. Ibrahim EM, Al-Idrissi HV, Al-Khattii AA, Al-Faraj AA, Al-Khatib RI, Kharouf JA. Piperacillin combined with aminoglycoside for empirical therapy of febrile granulocytopenic cancer patients. Hospital Acquired Infections and Antibiotic Policies Into the 90's; Royal College of Physician, London, United Kingdom, 1989.

31. Ibrahim EM, Al-Idrissi HY, Ahmad K, Ababtain W, Boukhary. Antiemetics for patients receiving anticancer therapy. Proceedings of the 5th Mediterranean Congress of Chemotherapy; O 71, 200, Cairo, 1986.

32. Ibrahim EM, Al-Idrissi HY. Breast cancer in low-risk population: the influence of age and menstrual status on disease pattern and survival. Proceedings of the 15th International Cancer Congress (UICC), Hamburg, West Germany, 1990(25.23.04).

33. Al-Idrissi HY, Ibrahim EM. Hodgkin's disease in adult in Saudi Arabia. Proceedings of the 15th International Cancer Congress (UICC), Hamburg, West Germany, 1990(25.23.07).

34. Chirayath H, Ibrahim EM, Kurashi NY. Stroke in Qassim area of Saudi Arabia. Proceedings of the Asian and Oceanian Congress of Neurology, Tokyo, Japan, 1991(0-l0-04).

35. Sadat Ali M, Ibrahim EM. Malignant bone tumors in pregnancy. Proceedings published in the Annals of Saudi Medicine, 1992.

36. Ibrahim EM, Ajaram D, Wiseibky R, Al-Idrissi HY. A multicenter trial on the use of

16


r-HuEpo in the management of cancer-related anemia. The International Working Group on the Management of Cancer-Related Anemia using r-HuEpo, Lucerne, Switzerland.

37. Ibrahim EM, Nassim F. M. An expert system for the prediction of life expectancy in patients receiving adjuvant therapy for early breast cancer. Proceeding of the American Society of Clinical Oncology, 1994 (Abstract No. 129).

35. Ibrahim EM, Nassim F. M. An expert system for the prediction of life expectancy in patients receiving adjuvant therapy for early breast cancer. Proceeding of the Saudi International Oncology Conference, Riyadh 1994.

36. Ibrahim EM, Nassim F. M. An expert system for the prediction of life expectancy in patients receiving adjuvant therapy for early breast cancer. Proceeding of the International Cancer Congress, National Cancer Institute, Cairo 1994.

37. Ibrahim EM, Nassim F. M. An expert system for the prediction of life expectancy in patients receiving adjuvant therapy for early breast cancer. Proceeding of the International Symposium on Computer and Health Information, Riyadh, Saudi Arabia, 1995.

38. Ibrahim EM, Al-Idrissi HY, Bunyan RF, Al-Mulhim FA, Al-Nabhan AA. Chemotherapy with MECOP-B for intermediate-grade and high-grade non-Hodgkin’s lymphoma in Saudi Arabia: Clinical results and analysis of prognostic factors. 1996 The First Pan Arab Cancer Conference and the Fourth Egyptian-French Cancer Congress, Cairo, Egypt, 1996.

39. Ibrahim EM, Al-Idrissi HY, Bunyan RF, Al-Mulhim FA, Al-Nabhan AA, Ibrahim RE. Chemotherapy with MECOP-B for intermediate-grade and high-grade non-Hodgkin’s lymphoma in Saudi Arabia: Clinical results and analysis of prognostic factors. The 26th Congress of the International Society of Hematology, Singapore, August, 1996.

40. Ibrahim EM, Bunyan RF, Al-Mulhim FA, Al-Nabhan AA, Ibrahim RE. Chemotherapy with MECOP-B for intermediate-grade and high-grade non-Hodgkin’s lymphoma in Saudi Arabia: Clinical results and analysis of prognostic factors. The European Society for Medical Oncology (21st ESMO Congress), Vienna, Austria, 1996.

41. Ibrahim EM. The concepts and limitations of meta-analysis: Lessons from the early breast cancer adjuvant trials. The International Conference on Cancer, Riyadh, Saudi Arabia, 1996.

42. Ibrahim EM. The effect of G-CSF and GM-CSF on chemotherapy-related oral mucositis. The Second Middle East Symposium on Hematopoietic Growth Factors, Dubai, United Arab Emirates, 1996.

43. Ibrahim EM. Screening for colorectal cancer: Examining the perplexity. The Fifth Meeting of the Saudi Gastroenterology Society, Al-Khobar Saudi Arabia, 1997.

44. Ibrahim EM, Al-Mulhim. Use of granulocyte-macrophage colony stimulating factor in chemotherapy induced oral mucositis in non-neutropenic cancer patients. Supportive Care in Cancer, San Antonio, Texas, March 14-17, 1998.

45. Ibrahim EM, Al-Mulhim. Use of granulocyte-macrophage colony stimulating factor in chemotherapy induced oral mucositis in non-

17


neutropenic cancer patients. American Society of Clinical Oncology, Los Angles, California, USA, May 16-17, 1998 (poster presentation, abstract # 335).

46. Ibrahim EM, Adnan A. Ezzat, Robert K. Stuart, Dahish S. Ajarim, Madras Raja;Stage III Breast Cancer: Single Institution Experience American Society of Clinical Oncology, Atlanta, Georgia, May 13-18, 1999 (Abstract 360).

47. Madras A. Raja, Adnan A. Ezzat, Ibrahim EM, Shouki Bazarbashi, Mohamed Rahal, Robert K. Stuart. Prospective Comparative Study of 5HT-3 Antagonists in Moderately Emetogenic Chemotherapy. American Society of Clinical Oncology, Atlanta, Georgia, May 13-18, 1999 (Abstract #2334).

48. Shouki Bazarbashi, Madras A. Raja, Adnan Ezzat, Said Kattan, Eric Lindstedt, Amjad eracha, Abdul H. Kardar, Talal Merdad, Chandrashekhar Pai, Mohammed Rahal, Adher Al-Sayed, Ibrahim EM, Kamal Hanash. Prospective Phase II Trial of Alternating Intravesical BCG and Interferon a-2b (IFN) in Superficial Transitional Cell Carcinoma (TCC) of the Urinary Bladder. American Society of Clinical Oncology, Atlanta, Georgia, May 13-18, 1999 (Abstract # 1289).

49. Robert Stuart, Adnan Ezzat, Ibrahim EM, Mohammed Ranginwala, Dahish Ajarim, Mahmmoud El-Foudeh, Madras Raja, Shouki Bazarbashi, Mohammed Rahal. CHOP vs. CHOP+High-Dose Tamoxifen in the Management of Aggressive Non-Hodgkin's Lymphoma: Interim Analysis of a Prospective, Randomized Trial. American Society of Clinical Oncology, Atlanta, Georgia, May 13-18, 1999 (Abstract #141).

50. Mohammed Rahal, Adnan A. Ezzat, John Berry, Madras A. Raja, Shouki Bazarbashi, Robert K. Stuart, Dahish Ajarim, Ibrahim EM. Chronic Administration of Etoposide (VP16) Followed by CNOP (Cyclophosphamide, Novantrone, Oncovin and Prednisone) in Elderly Patients (PTS) with Aggressive Non-Hodgkin's Lymphoma. American Society of Clinical Oncology, Atlanta, Georgia, May 13-18, 1999 (Abstract #127).

51. Adnan Ezzat, Ibrahim EM, Mohammed Ranginwala, Dahish Ajarim, Mahmmoud El-Foudeh, Madras Raja, Shouki Bazarbashi, Mohammed Rahal, Stuart RK. CHOP vs. CHOP+High-Dose Tamoxifen in the Management of Aggressive Non-Hodgkin's Lymphoma: Interim Analysis of a Prospective, Randomized Trial. American Society of Clinical Oncology-Panarab Meeting, Cairo, Egypt November 8-11, 1999.

52. Bazarbashi Shouki, Mohammaed Rahal, Adnan A. Ezzat, John Berry, Madras A. Raja, Shouki Bazarbashi, Robert K. Stuart, Dahish Ajarim, Ibrahim EM. Chronic Administration of Etoposide (VP16) Followed by CNOP (Cyclophosphamide, Novantrone, Oncovin and Prednisone) in Elderly Patients (PTS) with Aggressive Non-Hodgkin's Lymphoma. American Society of Clinical Oncology-Panarab Meeting, Cairo, Egypt November 8-11, 1999.

53. Madras A Raja, Adnan A. Ezzat, Ibrahim EM, Shouki Bazarbashi, Robert K. Stuart, Dahish Ajarim. Comparative study of non-Hodgkin’s Lymphoma between Saudi Arabia and USA. American Society of Clinical Oncology-Panarab Meeting, Cairo, Egypt November 8-11, 1999.

18


54. Ibrahim EM, Ezzat A, Raja M, Rahal M, Ajarim D, Mann B, Baloush A, Stuart RK, Bazarbashi S. Primary gastric non-Hodgkin’s lymphoma: Clinical Features, Management, and Prognosis of 185 Patients with Diffuse Large B-Cell Lymphoma. American Society of Clinical Oncology-Panarab Meeting, Cairo, Egypt November 8-11, 1999.

55. Ibrahim EM, Adnan A Ezzat, Madras M Raja, Mohammed M Rahal, Dahish S Ajarim, Bhuupinder Mann, Abed Baloush, Robert K Stuart, Shouki N Bazarbashi. PRIMARY LARGE-B CELL GASTRIC (LBCL) NON-HODGKIN'S LYMPHOMA: ANALYSIS OF 185 PATIENTS. King Faisal Specialist Hospital & Research Center, Riyadh, Saudi Arabia. American Society of Clinical Oncology, New Orleans, Louisiana, May 20-23, 2000 (Abstract 127).

56. Shouki Bazarbashi, Mohammed Rahal, Madras Raja, Mahmoud El Foudeh, Amer El Weshi, Adnan Ezzat, Dahish Ajarim, Ibrahim EM. King Faisal Specialist Hospital & Research Center, Riyadh, Saudi Arabia. CONVENTIONAL VERSUS HIGH DOSE CHEMOTHERAPY (HDC) FOLLOWED BY HEMATOPOIETIC STEM CELL TRANSPLANTATION (HSCT) FOR RELAPSED OR REFRACTORY HODGKIN'S DISEASE. American Society of Clinical Oncology, New Orleans, Louisiana, May 20-23, 2000 (Abstract 150).

57. Muhammad Memon, Amer El-Weshi, Shouki Bazarbashi, Adnan Ezzat, Ibrahim EM, Mohammed Rahal, Madras Raja. King Faisal Specialist Hospital & Research Center, Riyadh, Saudi Arabia. ETOPOSIDE/IFOSFAMIDE/CISPLATIN (VIP) IN THE TREATMENT OF EWING'S SARCOMA UNRESPONSIVE TO STANDARD THERAPY. American Society of Clinical Oncology, New Orleans, Louisiana, May 20-23, 2000 (Abstract 2218).

58. Amr N El-Weshi, Ibrahim EM, Adnan A Ezzat, Yasser Khafaga, Madras Raja, Shouki Bazarbashi, Dahish S Ajarim, King Faisal Specialist Hospital & Research Center, Riyadh, Saudi Arabia. LOCALIZED PRIMARY NASOPHARYNGEAL NON-HODGKIN'S LYMPHOMA (PNP-NHL): SINGLE CENTER EXPERIENCE WITH 47 PATIENTS. American Society of Clinical Oncology, New Orleans, Louisiana, May 20-23, 2000 (Abstract 132).

59. Dahish Ajarim, Ibrahim EM, Adnan A Ezzat, Abed Baloush, Zeinab H Hussain. King Faisal Specialist Hospital & Research Center, Riyadh, Saudi Arabia. PREGNANCY-ASSOCIATED BREAST CANCER: CASE-CONTROL STUDY. American Society of Clinical Oncology, New Orleans, Louisiana, May 20-23, 2000 (Abstract 518).

60. Adnan A Ezzat, Ibrahim EM, Dahish S Ajarim, Mohammed M Rahal, Madras M Raja, Robert K Stuart, Asma M Tulbah, Alaa Kandil, Osama A Al-Malik, Shouki N Bazarbashi. High Complete Pathological Response in Locally Advanced Breast Cancer using Paclitaxel and Cisplatin. The 23rd San Antonio Breast Conference, San Antonio, Texas, December 6-9, 2000.

61. Rahal MM, Ezzat AA, Ibrahim EM, Ajarim DS, Raja A, Stuart RK, Tulbah AM, Kandil A, Bazarbashi SN. Neoadjuvant high-dose Sequential Chemotherapy with Adriamycin (A), Paclitaxel (P), and Cyclophosphamide is Feasible and Effective in Poor Prognostic Patients with Locally Advanced Breast Cancer (LABC). The 23rd San Antonio Breast Conference, San Antonio, Texas, December 6-9, 2000.

19


62. Ibrahim EM.Early Breast Cancer. Pathology of the Breast, KFSH & RC, Jeddah, January 2001, Saudi Arabia.

63. Ibrahim EM. Primary Intestinal Non-Hodgkin’s Lymphoma, Update in Hematology, January 2001, Jeddah, Saudi Arabia.

64. D Ajarim, M El Foudeh, Y Khafaga, A Bajouda, A Ezzat, Ibrahim EM, S Bazarbashi, M Raja, M Rahal, C Pai, A El Weshi, A Baloush. Primary Non-Hodgkin’s Lymphoma of Bone in Adults. American Society of Clinical Oncology, San Francisco, California 12-19, 2001 (Abstract 2674).

65. Ibrahim EM, Adnan Ezzat, Amr El Weishi, Justin Martin, Yasser Khafaga, Dahish Ajarim, Mahmoud El Foudah, Emanuele Zucca. Primary Intestinal Diffuse Large B-Cell Non-Hodgkin’s Lymphoma: Clinical Features, Management, and Prognosis of 66 Patients. American Society of Clinical Oncology, San Francisco, California 12-16, 2001 (Abstract 1182).

66. Baslaim MM, Ibrahim EM, Al-Malik O, Al-Sobhi SS, Ezzat A, Ajarim D, Tulbah A, ChaudharyMA. Decreased axillary lymph node retrival after neoadjuvant chemotherapy in patients with locally advanced breast cancer. The 7th Annual Multidisciplinary Symposium on Breast Disease, Ame Island, Florida (2002).

67. Baslaim MM, Ibrahim EM, Al-Malik O, Al-Sobhi SS, Ezzat A, Ajarim D, Tulbah A, ChaudharyMA. Decreased axillary lymph node retrival after neoadjuvant chemotherapy in patients with locally advanced breast cancer. The 3rd Annual American Society of Breast Surgeons, Boston, MA (2002).

68. Ibrahim EM. The importance of Clinical Trials. Clinical Trials: Ethical Issues, Jeddah, Saudi Arabia (2005)

69. Ibrahim EM. Saudi Experience, Update on Oncology, Cape Town, South Africa (2005)

70. Ibrahim EM. Bronchogenic Carcinoma: What is beyound Surgery, Saudi Cancer Society and the Arab Thoracic Association, Jeddah, Saudi Arabia (2005)

71. Ibrahim EM. Breast Cancer Screening, Women Health Update, Jeddah, Saudi Arabia (2006)

72. Ibrahim EM. Writing Results and Discussion, Writing Biomedical Research Paper, Jeddah, Saudi Arabia (2006)

73. Ibrahim EM. Interactive Computer Applications on Biostatistics, Jeddah, Saudi Arabia (2006)

74. Ibrahim EM. Basics of Biostatistics, Biostatistics Course, Jeddah, Saudi Basics of Biostatistics, Biostatistics Course, Jeddah, Saudi Arabia (2006)Arabia (2006)

75. Ibrahim EM. Intoduction to Healthinformatics, Jeddah, Saudi Arabia (2006)

76. Ibrahim EM. Informed Consent, Clinical Trials: Ethical Issues, Jeddah, Saudi Arabia (2006)

77. Ibrahim EM. Complimentry and Alternative Medicine: The Evidence for Evidence, Early Breast Cancer Conference, Jeddah, Saudi Arabia (2007)

78. Ibrahim EM. Angiogenesis in Metastatic Breast Cancer, Oncology Update, Cairo, Egypt (2007)

79. Ibrahim EM. Role of Primary Physicians in Oncology Practice, Jeddah, Role of Primary Physicians in Oncology Practice, Jeddah, Saudi Arabia (2007)Saudi Arabia (2007)

20


80. Ibrahim EM. Breast Cancer, The Best of the Decade, Jeddah, Saudi Arabia (2008)

81. Ibrahim EM. A. M. Zeeneldin, B. Bin Sadiq. The present and the future of breast cancer burden in the Kingdom of Saudi Arabia. J Clin Oncol 26: 2008 (May 20 suppl; abstr 22089)

82. Ibrahim EM. Liptomeningeal carcinomatossis: Unusual Presentation. GSK sponsored meeting, St Gallen, Switzerland (2009).

83. Ibrahim EM. Cetuximab in Metastatic Colorectal Cancer: Meta-analysis of Efficacy Based on K-Ras Mutations Status. Beirut, Lebanon (2010).

84. Ibrahim EM. Questions and Answers in Biomedical Research, Oncology Update 2012, Jeddah, Saudi Arabia.

85. Ibrahim EM. Anti-Angiogenesis: Promising Strategy and Formidable Challenge. Istanbul, Turkey.

21


EDITED BOOKS & CHAPTERS IN BOOKS

1. El-Mawla NG, Ibrahim EM, El-Serafy M. The use of systemic chemotherapy in the management of advanced breast cancer. In: Breast Cancer: A Comprehensive Approach (1st Edition), Eds. Omer S, Contesso G, 161-l69, 1984. The book was published by the Cairo Medical Syndicate Scientific Committee and supported by the Egyptian Ministry of Health and the Egyptian Academy of Scientific Research and Technology. The book was written by several experts in breast cancer disease: pathologists, surgeons, medical oncologists, radiotherapists, and epidemiologists from Saudi Arabia, Egypt, France (Gustave-Roussy Institute), USA (The American Cancer Society). It addresses various aspects of breast cancer.

2. Ibrahim EM, El-Serafy M. Chemotherapy in the management of metastatic breast cancer. In: Breast Cancer (2nd Edition), Eds. Omer S, Contesso G, 126-131, 1987. The book was published by Korba, London. The book was written with contribution from authors from Egypt, France, USA and Saudi Arabia to provide an updated experience of all controversial issues in the diagnosis and management of breast cancer.

3. Ibrahim EM. The editor of book titled "Comprehensive Approach to Clinical Examination". It contained 15 chapters in 535 pages. The book is designed in a way that should make understanding, learning and studying easier. In preparing it, many standard textbooks and monographs have been reviewed. The book contained many illustrations of key examination techniques, graphs, and easily understood tables of important facts; its style was intended to capture the reader's interest and imagination. Though several chapters were written by different contributors, a unified format is maintained throughout. I believe that this book was able to satisfy the need for a clear guide to clinical medicine, and it has certainly competed favorably with similar books in this respect, nevertheless, it was never predestined to serve as an extensive textbook in theoretical medicine. Although a chapter was devoted to common symptoms, the cardinal symptoms of organ systems were reinforced under the appropriate chapters. Some of the commoner and more important diseases have been covered in a simplified way. Moreover, a chapter that introduces the readers to the basis of radiological investigations; and another dedicated to illustrate the basic principles of electrocardiography, were included. The two chapters are added to ensure a quick basic understanding of these important investigations. A third chapter was also added to promote the philosophy of medical informatics. Neither, pediatric nor gynecological examination were discussed.

4. Ibrahim EM. The editor of a new book “Comprehensive Approach to Case Studies in Medicine”. The book addressed a novel approach to problem-oriented clinical medicine. It contained 40 chapters with

22


contributions from several faculty staff at King Faisal University and consultants at King Faisal Specialist Hospital. The book came in 239 pages.

5. Ibrahim EM, El-Serafy M. Chemotherapy in the management of metastatic breast cancer. In: Breast Cancer (3rd edition), Eds. Omer S, Contesso G, 137-142, 1997. The book was published by the Association Medicale Franco Egyptienne.

6. Ibrahim EM, Asma Tulbah. Basic Principles of Tumor Pathology and Biology. In: Basic Principles of Nuclear Medicine (1st edition), Eds. Abdelhamid El-Gazzar, Springer-Verlarg, New York, 2001, p 169-178.

7. El-Gazzar, Ibrahim EM. Nuclear Medicine Basis of Bone Tumors. In: Basic Principles of Nuclear Medicine (1st edition), Eds. Abdelhamid El-Gazzar, Springer-Verlarg, New York.

8. Ibrahim EM. In: Textbook of Tropical Surgery. Eds. Refaat Kamel and John Lumley, Westminister Publishing Ltd., London, 2004, Chapter 70.

9. Ibrahim EM, Al-Maghrabi J A. Basis of Tumor Imaging 1: Principles of Tumor Pathology and Biology. In: Basic Principles of Nuclear Medicine (2nd edition), Eds. Abdelhamid El-Gazzar, Springer-Verlarg, New York, 2006, p 264-277.

10. Ibrahim EM, Ezzat AA. Cancer Control in Asia Pacific – Saudi Arabia

23


PUBLICATIONS

1. Klimo P, Ibrahim E: Anaphylactic reaction to methotrexate used in high doses as an adjuvant treatment of osteogenic sarcoma. Cancer Treat Rep 1981, 65(7-8):725.

2. Leahy MF, Ibrahim EM, Worth AJ: Primary hepatic lymphoma: Two case reports and a review of the literature. Medical and Pediatric Oncology 1982, 10(6):575-581.

3. Ibrahim A, Ibrahim E, Mitry N, Abdul-Satir A, Kuppa A: Spinal cord compression due to intrathoracic extramedullary haematopoiesis in homozygous thalassaemia. Journal of Neurology, Neurosurgery & Psychiatry 1983, 46(8):780-782.

4. Ibrahim AW, Ibrahim EM, Mitry NM, Abdul-Satir A, Kuppa A: Spinal cord compression due to intrathoracic extramedullary haematopoiesis in homozygous thalassaemia. J Neurol Neurosurg Psychiatry 1983, 46(8):780-782.

5. Silver HK, Ibrahim EM, Evers JA, Thomas JW, Murray RN, Spinelli JJ: Adjuvant BCG immunotherapy for stage I and II malignant melanoma. Can Med Assoc J 1983, 128(11):1291-1295.

6. Ibrahim EM, Al-Idrissi H, Al-Farag A, Al-Tamimi D, Perry W: Situs inversus totalis with embryonal cell carcinoma of ovaries. Gynecol Oncol 1984, 18(2):270-273.

7. Al-Idrissi HY, Ibrahim EM, Abdel Satir A, Satti MB, Al-Kasem S, Al-Qurain A: Primary hepatocellular carcinoma in the eastern province of Saudi Arabia: treatment with combination chemotherapy using 5-fluorouracil, Adriamycin and mitomycin-C. Hepatogastroenterology 1985, 32(1):8-10.

8. Ibrahim EM, Anim JT, Al-Idrissi H, Al Mohaya S, Al Dossary J, Grant CS: Abdominal tuberculosis: a frequent diagnostic challenge. Ann Trop Med Parasitol 1985, 79(2):163-167.

9. Ahmed R, Bopp С BA, Kasattya S, Al-Idrish H, Satti M, Al-Quorain A, Ibrahim E, Al-Fiar F: Bibliography of the current world literature. Antimicrob Agents Chemother 1986, 30:694-700.

10. AL NAHDI M, SULIIMAN AM, IBRAHIM E, AL IDRISSI H: Prevalence of allergic conditions in an out-patient population in the Eastern Province of Saudi Arabia. Folia allergologica et immunologica clinica 1986, 33(6):453-459.

11. Al-Freihi H, Al Mohaya S, Al Mohsen M, Ibrahim E, Al-Sohaibani M, Twum-Danso K, Al-Idrissi H: Brucellosis in Saudi Arabia: diverse manifestation of an important cause of pyrexial illness. Ann Saudi Med 1986, 6(2):95-100.

12. Al-Freihi HM, Al-Idrissi HY, Al-Quorain A, Al-Mohaya SA, Al-Hamdan AR, Ibrahim EM: The pattern of colonic diseases in the

24


Eastern Province of Saudi Arabia. J Trop Med Hyg 1986, 89(1):23-27.

13. Ibrahim AW, Farag H, Naguib M, Ibrahim E: Neuroepithelial (colloid) cyst of the third ventricle in identical twins. Case report. J Neurosurg 1986, 65(3):401-403.

14. Ibrahim AW, Satti MB, Ibrahim EM: Extraspinal meningioma: case report. Journal of neurosurgery 1986, 64(2):328-330.

15. Ibrahim E, Satti M, Al Idrissi H, Higazi M, Magbool G, Al Quorain A: Oral cancer in Saudi Arabia: the role of alqat and alshammah. Cancer detection and prevention 1986, 9(3-4):215.

16. Ibrahim EM, Al-Idrissi HY, Ibrahim A, Absood G, Al-Dossary E, Al-Jammaa A, Al-Ethan S, Eliopoulos A: Antiemetic efficacy of high-dose dexamethasone: Randomized, double-blind, crossover study with high-dose metoclopramide in patients receiving cancer chemotherapy. European Journal of Cancer and Clinical Oncology 1986, 22(3):283-288.

17. Ibrahim EM, Satti MB, Al Idrissi HY, Higazi MM, Magbool GM, Al Quorain A: Oral cancer in Saudi Arabia: the role of alqat and alshammah. Cancer Detect Prev 1986, 9(3-4):215-218.

18. Ibrahim EM, Satti MB, Al-Idrissi HY, Abdel Satir A, Al-Mohaya SA, Al-Qourain A, Al-Freihi H, Abssod GH: Combination chemotherapy only for stage II non-Hodgkin's lymphoma. Eur J Cancer Clin Oncol 1986, 22(2):199-203.

19. Al Nahdi M, Shahed Omer M, Ibrahim E, Al-Idrisi H: Skin testing in an allergy affected population of Saudi Arabia. Allerg Immunol (Paris) 1987, 19(4):167-168, 170-161.

20. Al-Freihi HM, Al-Mohaya SA, Ibrahim EM, Al-Idrissi HY, Baris I: Extrapulmonary tuberculosis: diverse manifestations and diagnosis challenge. East Afr Med J 1987, 64(5):295-301.

21. Al-Idrissi HY, Satti MB, Al-Quorain A, Ibrahim EM, Al-Fiar FZ: Granulomatous oesophagitis: a case of tuberculosis limited to the oesophagus. Ann Trop Med Parasitol 1987, 81(2):129-133.

22. Ibrahim EM, Al-Sohaibani MO, Al-Suleiman SA, Satti MB, Al-Mulhim FA, Qaddura F: Tuberculosis of the pancreas: a rare cause of obstructive jaundice and portal hypertension. Trop Gastroenterol 1987, 8(3):167-172.

23. Ibrahim EM A-IH, Al-Mohaya S, Larbi EB, Al-Nahdy MS, Al-Hassan AY, Al-Mulhim FA, Al-Dossary J: Chest roentgenography in medical emergency. Annals of Saudi Medicine 1987, 7:57-61.

24. Luqman W, Ibrahim E: The outcome for some methods evaluation of clinical students. Mater Med Pol 1987, 19(1):60-61.

25. Taha SA, Satti MB, Mitry NF, Al-Idrissi HY, Ibrahim EM: Giant bladder diverticulum: an unusual presentation. Br J Urol 1987, 59(2):189-190.

25


26. al Quorain A, Satti MB, al Idrissi HY, Ibrahim EM, al Freihi H, al-Hamdan AR, al Dossary J, Abdel Hadi M: Digestive system malignancies in the eastern province of Saudi Arabia: an analysis of 158 patients. Cancer Detect Prev 1988, 11(3-6):331-336.

27. Al-Idrissi H, Ibrahim E, Abdullah K, Ababtain W, Boukhary H, Macaulay H: metoclopramide and diphenhydramine. Br J Cancer 1988, 57:308-312.

28. al-Idrissi HY, Ibrahim EM, Abdullah KA, Ababtain WA, Boukhary HA, Macaulay HM: Antiemetic efficacy of high-dose dexamethasone: randomized, double-blind, crossover study with a combination of dexamethasone, metoclopramide and diphenhydramine. Br J Cancer 1988, 57(3):308-312.

29. Al-Quorain A, Ibrahim EM, Al-Ghassab G, Al-Mohana F, Baris I: Use of flexible fiberoptic bronchoscopy in pulmonary diseases--analysis of outcome and prediction of clinically useful studies. Indian J Chest Dis Allied Sci 1988, 30(3):167-175.

30. Ibrahim EM, Satti MB, Al-Idrissi HY, Al-Mulhim FA, Abssod GH, Abdel Jabar A: Non-Hodgkin's lymphoma in Saudi Arabia: prognostic factors and an analysis of the outcome of combination chemotherapy only, for both localized and advanced disease. Eur J Cancer Clin Oncol 1988, 24(3):391-401.

31. Ibrahim EM A-FH, Ryhan TI, Al-Sohaibani MO.: Comparative study of students' performance at a premedical, preclinical, and clinical levels in a medical school. Annals of Saudi Medicine 1988, 8(6):481-484.

32. Ibrahim EM SM, Naguib M, Absood GH, Al-Mulhim FA, Al-Ghassab G. : Hepatocellular carcinoma in Saudi Arabia: Evaluation of prognostic factors. Annals of Saudi Medicine 1988, 8(5):329-335.

33. al-Freihi HM, al-Qurain A, al-Gindan Y, Ibrahim EM, Satti MB, Twum-Danso K, al-Idrissi HY, al-Ghassab G, al-Hamdan A: Campylobacter pylori in Saudi patients undergoing upper gastrointestinal endoscopy: prevalence and effect of conventional therapy. Hepatogastroenterology 1989, 36(6):516-518.

34. Al-Nahdi MS, Ibrahim EM: The prevalence of allergic disorders in Saudi Arabia: preliminary analysis based on surveying 300 individuals. Allerg Immunol (Paris) 1989, 21(6):241-242.

35. Ibrahim AW, Chowdhary UM, Ammar A, Ibrahim EM: The outcome of head injury: the Saudi experience. Neurol Med Chir (Tokyo) 1989, 29(9):816-819.

36. Ibrahim E, Al-Idrissi H: MECOP-B in the management of non-Hodgkin's Iymphoma: Preliminary analysis of prognostic

26


factors and total dose-intensity. The Cancer Journal 1989, 2(12):444-449.

37. IBRAHIM E, AL-IDRISSI H, AL-MULHIM F, EL-HASSAN A, AL-KHATI A, AL-KHAROUF J, AL-KHATIB R: The impact of routine chest radiography on the management of febrile neutropenic adult cancer patients. Cancer journal (Villejuif) 1989, 2(11):395-399.

38. Ibrahim EM, Uwaydah A, al-Mulhim FA, Ibrahim AM, el-Hassan AY: Tuberculosis in patients with malignant disease. Indian J Cancer 1989, 26(2):53-57.

39. Ibrahim EM A-IH, Al-Mulhim FA, El-Hassan AY, Al-Khatti AA, Al-Khatib RI. : The impact of routine chest radiography on the management of febrile neutropenic adult cancer patients. The Cancer Journal 1989, 2(11):395-399.

40. Ibrahim EM A-MS, Al-Idrissi HY, Al-Jasser HH, Al-Fhaid SA, Ibrahim FAS. : Clinical usefulness of predicted creatinine clearance in cancer patients receiving cisplatin therapy. Annals of Saudi Medicine 1989, 9(5):439-442.

41. Sadat-Ali M, Ibrahim EM: Malignant bone tumours in pregnancy (a report of two cases and review of literature). Indian J Cancer 1989, 26(3):151-155.

42. Wahab A, Ibrahim M, Chowdhary UM, Ammar A, Ibrahim EM: The outcome of head injuries: the Saudi experience. Nagoya J Med Sci 1989, 51(1-4):1-6.

43. Al-Gindan YM A-QA, Ibrahim EM, Al-Freihi H, Al-Mohsen MF, Hussein A, Saied 1, Al-Ghassab G, Al-Mohana F. : Acute myocardial infarction in the Eastern Province of Saudi Arabia: retrospective study of 264 patients. Annals of Saudi Medicine 1990, 10(2):129-136.

44. Al-Sohaibani MO SM, Ibrahim EM, Al-Sowayan S. : Histologic patterns of lymphadenopathy in the Eastern Province of Saudi Arabia. Annals of Saudi Medicine 1990, 10(5):516-520.

45. El-Hassan AY A-MF, Ibrahim EM, Al-Awami M. Retrospective appraisal of 300 consecutive mammographic studies: Retrospective appraisal of 300 consecutive mammographic studies. Annals of Saudi Medicine 1990, 10(3):285-290.

46. Ibrahim EM: Late relapse of Hodgkin's disease after 25 years. Indian J Cancer 1990, 27(1):17-19.

47. Ibrahim EM: Pattern and prognosis of breast cancer at a referral center in Saudi Arabia. Breast Disease 1990, 3:187-198.

48. Ibrahim EM A-IH, Al-Khatti AA, Al-Faraj AA, Al-Gindan Y, Al-Khatib RI, Al-Kharouf JA. : Piperacillin combined with aminoglycoside for empirical therapy of febrile granulocytopenic cancer patients. Cancer Therapy and Control 1990, 1:205-211.

27


49. Satti M, Twum-Danso K, Al-Freihi H, Ibrahim E, Al-Gindan Y, Al-Quorain A, Al-Ghassab G, Al-Hamdan A, Al-Idrissi H: Helicobacter pylori-associated upper gastrointestinal disease in Saudi Arabia: a pathologic evaluation of 298 endoscopic biopsies from 201 consecutive patients. The American journal of gastroenterology 1990, 85(5):527.

50. Satti MB, al-Freihi H, Ibrahim EM, Abu-Melha A, al-Ghassab G, al-Idrissi HY, al-Sohaibani MO: Hepatic granuloma in Saudi Arabia: a clinicopathological study of 59 cases. Am J Gastroenterol 1990, 85(6):669-674.

51. Satti MB, Melha AA, al-Sohaibani MO, al-Sowayan S, al-Quorain A, Ibrahim EM: Splenic foam cells: a clinico-pathologic analysis of 92 splenectomized patients. Acta Haematol 1990, 83(1):9-15.

52. Satti MB, Twum-Danso K, al-Freihi HM, Ibrahim EM, al-Gindan Y, al-Quorain A, al-Ghassab G, al-Hamdan A, al-Idrissi HY: Helicobacter pylori-associated upper gastrointestinal disease in Saudi Arabia: a pathologic evaluation of 298 endoscopic biopsies from 201 consecutive patients. Am J Gastroenterol 1990, 85(5):527-534.

53. A-IDRISSI H, LARBI E, IBRAHIM E, AL-FREIHI H, AL-MOHAYA S, AL-JASER H, SUKKAR H: A RANDOMIZED, DOUBLE-BLIND, CROSSOVER STUDY OF NIFEDIPINE AND CAPTOPRIL INMILD AND MODERATELY SEVERE HYPERTENSION IN SAUDIS. Current therapeutic research 1991, 49(3):340-350.

54. al-Freihi HM, al-Hamdan A, al-Qurain A, al-Gindan YM, Ibrahim EM, al-Ghassab G, Nabi HI: A single nocturnal dose of famotidine for the treatment of duodenal ulcer: evaluation of efficacy and safety. Trop Gastroenterol 1991, 12(2):77-82.

55. al-Ghamdi MS, Ibrahim EM, al-Idrissi HY, al-Khatti AA, al-Faraj A: Antiemetic efficacy of cimetidine randomized, double-blind, crossover study with dexamethasone in cancer patients receiving emetogenic chemotherapy. Ann Oncol 1991, 2(7):517-518.

56. al-Idrissi HY, Ibrahim EM: Hodgkin's disease in adults in Saudi Arabia. Clinical features, prognostic factors and an analysis of therapy. Outcome of combination chemotherapy only, for both localized and advanced disease. Int J Cancer 1991, 47(6):822-826.

57. Al-Idrissi HY LE, Ibrahim EM, Al-Freihi HM, Al-Mohaya SA, Al-Jasser H, Sukkar H.: A randomized double-blind cross over study of nifedipine and captopril in mild and moderately severe hypertension in Saudis. Current Therapeutic Research 1991, 49(3):340-350.

28


58. Al-Khadra A MF, Ibrahim EM: Patients' knowledge of hypertension and its management. Journal of Saudi Heart Association 1991, 3(3):106-109.

59. Al-Sohaibani M, Satti MB, Ibrahim EM, Al-Sowayan S: Reply: Histological patterns of lymphadenopathy in the eastern province. Ann Saudi Med 1991, 11(6):716-717.

60. Hegazy MM, Ibrahim EM: The pattern and outcome of burn injuries at a burn unit in Saudi Arabia: Retrospective analysis of consecutive 501 patients. Ann Saudi Med 1991, 11(3):255-259.

61. Ibrahim E: Pattern and prognosis of breast cancer: data from the Eastern Province of Saudi Arabia. Saudi medical journal 1991, 12(3):227-231.

62. Ibrahim E, Al-Idrissi H, Al-Freihi H, Al-Gindan Y: Evaluation of students' performance and examination procedures in final certifying examinations in internal medicine (1982-1988). Annals of Saudi medicine 1991, 11(3):325.

63. Ibrahim E, Al-Muhanna F, Saied I, Al-Jishi F, Al-Idrissi H, Al-Khadra A, Al-Shehabi A: Public knowledge, misperceptions, and attitudes about cancer in Saudi Arabia. Annals of Saudi medicine 1991, 11(5):518.

64. Ibrahim EM, Al-Idrissi HY, Al-Freihi HM, Al-Gindan YM: Evaluation of students' performance and examination procedures in final certifying examinations in internal medicine (1982-1988). Ann Saudi Med 1991, 11(3):325-330.

65. Ibrahim EM, al-Idrissi HY, al-Khadra AH, Kurashi NY, al-Jishi FM, Saied I, al-Mohana FA, al-Shehabi AF: Women's knowledge of and attitude toward breast cancer in a developing country: implications for program interventions--results based on interviewing 500 women in Saudi Arabia. J Cancer Educ 1991, 6(2):73-81.

66. Ibrahim EM, Al-Muhanna FA, Saied I, Al-Jishi FM, Al-Idrissi HY, Al-Khadra AH, Al-Shehabi AF: Public knowledge, misperceptions, and attitudes about cancer in Saudi Arabia. Ann Saudi Med 1991, 11(5):518-523.

67. Ibrahim EM, Satti MB, Koreich OM, Al-Uqali IA, Al-Mulhim FA: Hodgkin's disease involving the urinary bladder: A case report. Ann Saudi Med 1991, 11(3):349-351.

68. Ibrahim EM IH, Al-Freihi HM, Al-Gindan YM: Evaluation of students performance and examination procedures in final certifying examinations in internal medicine (1982-l988). . Annals of Saudi Medicine 1991, 11(3):325-330.

69. Ibrahim EM SM, Koreich OM, Al-Uqali 1, Al-Mulhim FA. : Hodgkin's disease involving the urinary bladder. Annals of Saudi Medicine 1991, 11(3):349-351.

29


70. al-Idrissi HY, Ibrahim EM, Kurashi NY, Sowayan SA: Breast cancer in a low-risk population. The influence of age and menstrual status on disease pattern and survival in Saudi Arabia. Int J Cancer 1992, 52(1):48-51.

71. El-Hassan AY, Ibrahim EM, Al-Mulhim FA, Nabhan AA, Chammas MY: Fatty infiltration of the liver: analysis of prevalence, radiological and clinical features and influence on patient management. British journal of radiology 1992, 65(777):774-778.

72. Ibrahim EM, Alidrissi HY, Al-Khadra A, et al.: Ondansetron in the management of emesis in patients receiving emetogenic chemotherapy. Cancer, Research, Therapy and Control 1992, 3:1-6.

73. Kurashi NY, al-Hamdan A, Ibrahim EM, al-Idrissi HY, al-Bayari TH: Community acquired acute bacterial and atypical pneumonia in Saudi Arabia. Thorax 1992, 47(2):115-118.

74. Al-Idrissi H, Ibrahim E, Hassan F, Al-Nabhan A: A randomised, double-blind, crossover study of cilazapril and captopril in mild to moderately severe hypertension in Saudis. JOURNAL OF DRUG DEVELOPMENT 1993, 5:215-215.

75. al-Idrissi HY, Ibrahim EM: Hodgkin's disease in adults in Saudi Arabia. Clinical features, prognostic factors and an analysis of therapy. Outcome of combination chemotherapy only, for both localized and advanced disease. Int J Cancer 1993, 47(6):822-826.

76. al-Idrissi HY, Ibrahim EM, Hassan F, al-Nabhan AA, al-Khadra AH, Muhanna FA: A randomized, double-blind, crossover study of cilazapril and captopril in mild to moderately severe hypertension in Saudis. Journal of Drug Development 1993, 5(4):215-223.

77. Al-Muhanna F, Ghassab G, Al-Rahman I, Al-Qurain A, Ibrahim E, Malhotra K, Al-Mohaya S: Acute renal failure as seen in a hemolysis unit. Saudi Med Journal 1993, 14(5):432-435.

78. Al-Mulhim FA, Ibrahim EM, Sowayan SA, L W: An impact of decision analysis on the management of advanced hepatocellular carcinoma. Cancer Research, Therapy and Control 1993, 3(273-281).

79. Sadat-Ali M, El-Hassan AY, Ibrahim EM, Al-Frehi H, Al-Muhanna F: Postmenopausal osteoporosis in Saudi women: A pilot screening. Ann Saudi Med 1993, 13(3):272-274.

80. Al-Bar A, Ibrahim E, Tamimi T, Assuhaimi S, Ibrahim A: Hodgkin’s and non-Hodgkin’s lymphoma: Analysis of population-based data from the Eastern Province of Saudi Arabia. Saudi Med J 1994, 15(4):290-294.

81. Al-Khadra A, Ladipo G, Hussain A, Ibrahim E, Al-Gindan Y: In-hospital mortality of acute myocardial infarction in Saudi

30


Arabia. Journal of the Saudi Heart Association 1994, 6(2):123-127.

82. Al-Mulhim FA, Ibrahim EM: Magnetic resonance imaging of the spine: An initial experience. Ann Saudi Med 1994, 14(4):333-337.

83. Al-Quorain A, Ammar A, Al-Awami M, Hegazi M, HA E-M, Ibrahim E, Al-Muezen Y, Nassim F, Al-Gindan Y, Al-Freihi H: Comparison of intravenous famotidine and rantidine in suppressing gastric acid secretion in critically ill patients. Current Therapeutic Research 1994, 55(10):1263-1270.

84. al-Quorain A, Satti MB, al-Hamdan AR, al-Gindan Y, Ibrahim E, Khatib R, al-Freihi H: Pattern of chronic liver disease in the eastern province of Saudi Arabia. A hospital-based clinicopathological study. Trop Geogr Med 1994, 46(6):358-360.

85. Al-Mulhim F, Ibrahim E: Evaluation of students’ performance in diagnostic radiology. Journal of the Bahrain Medical Society 1995, 17(1):30-34.

86. Al-Mulhim FA, Ibrahim EM, El-Hassan AY, Moharram HM: Magnetic resonance imaging of tuberculous spondylitis. Spine 1995, 20(21):2287-2292.

87. Al-Sultan A, Ibrahim E: Factors influencing medical student’s career preferences. Journal of the Bahrain Medical Society 1995, 7(1):7-12.

88. Ibrahim EM: Information Superhighway…….. Are We in the Fast Lane? Journal of family & community medicine 1995, 2(1):9.

89. Al Quorain A, Ibrahim E, Al Sultan A: Diagnostic and therapeutic value of ERCP and prediction of outcome: A retrospective analysis. Saudi Journal of Gastroenterology 1996, 2(3):138.

90. Al Tamimi T, Al-Bar A, Al-Suhaimi S, Ibrahim E, Ibrahim A, Wosornu L, Gabriel G: Lung cancer in the Eastern region of Saudi Arabia: A population-based study. Annals of Saudi medicine 1996, 16(1):3.

91. Al Tamimi TM, Al-Bar A, Al-Suhaimi S, Ibrahim E, Ibrahim A, Wosornu L, Gabriel GS: Lung cancer in the Eastern region of Saudi Arabia: A population-based study. Ann Saudi Med 1996, 16(1):3-11.

92. Al-Bar A, Ibrahim E, Al-Tamimi T, Assuhaimi S, Ibrahim A, Gabriel G, Mishriky A: Leukemia in the eastern region of Saudi Arabia: A population-based study (1987-1988). Annals of Saudi medicine 1996, 16(5):521.

93. Ibrahim E, Nassim F, Ibrahim R: Simulation model for predicting survival in women receiving adjuvant therapy for early breast cancer. The Cancer Journal from Scientific American 1996, 2(4):234-240.

31


94. Ibrahim E, Nassim F, Ibrahm R: Simulations model for predicting survival in women receiving adjuvant therapy for early breast cancer. The cancer journal from Scientific American 1996, 2(4):234.

95. Ibrahim EM, Bunyan RF, al-Mulhim FA, al-Nabhan AA, Ibrahim RE: Chemotherapy with MECOP-B for intermediate-grade and high-grade non-Hodgkin's lymphoma in Saudi Arabia: clinical results and analysis of prognostic factors. Acta Haematol 1996, 96(3):126-134.

96. Mohammed E, Nur M, Kurashi N, Ibrahim E, Ammar K: Survival after stroke in Saudis: a hospital based study. The Journal of Family and Community Medicine 1996, 3(1):48-52.

97. Mohammed EGE, Nur MA, Kurashi NY, Ibrahim E, Ammar K: Survival after stroke in Saudis: A hospital based study. Journal of family & community medicine 1996, 3(1):48.

98. Al Tamimi TM, Ibrahim EM, Ibrahim A-WM, Al-Bar AA, Assuhaimi SA, Gabriel GS, Mishriky AM, Al-Idrissi HY, Al-Sohaibani MO, Al-Sibai MH: Cancer in the eastern region of Saudi Arabia: a population-based study (1987-1988). Annals of Saudi medicine 1997, 17:53-65.

99. Al-Bar A, Al-Tamimi T, Ibrahim E, Ibrahim A: Establishing a computerized tumor registry: the Eastern Province experience. Saudi Medical Journal 1997, 18(5):488-491.

100. Al-Tamimi T, Ibrahim A, Mishriky A, Gabriel G, Ibrahim E, Al-Bar A, Assuhaimi S: Thyroid cancer in the Eastern Region of Saudi Arabia: a population-based study (1987-1988). Saudi Medical Journal 1997, 18(4):374-380.

101. Al-Tamimi T, Ibrahim A-W, Mishriky A, Gabriel G, Ibrahim E, Al-Bar A, Assuhaimi S: Thyroid cancer in the Eastern Region of Saudi Arabia: A population-based study (1987-1988). Saudi medical journal 1997, 18(4):374-380.

102. Ibrahim EM, Al-Mulhim FA: Effect of granulocyte-macrophage colony-stimulating factor on chemotherapy-induced oral mucositis in non-neutro-penic cancer patients. Medical Oncology 1997, 14(1):47-51.

103. Al-Mulhim F, Ibrahim E, Al-Nabhan A, Ibrahim R, Nassim F, Ladipo G: Clinical prediction rule for pulmonary infiltrates. Saudi medical journal 1998, 19(3):306-312.

104. Ibrahim E, Al-Mulhim F: The effect of GM-CSF in chemotherapy-induced oral mucositis in non-neutropenic cancer patients. Biotherapy in Cancer 1998, 2(3):71-73.

105. Ibrahim E, Al-Mulhim F, Al-Muhanna F, Al-Amri A: The effect of GM-CSF in chemotherapy-induced oral mucositis in non-neutropenic cancer patients. Journal of Family and Community Medical 1998, 5, 37-43(2):37-43.

32


106. Ibrahim EM, Al-Mulhim FA, Al-Amri A, Al-Muhanna FA, Ezzat AA, Stuart RK, Ajarim D: Breast cancer in the eastern province of Saudi Arabia. Medical oncology 1998, 15(4):241-247.

107. Ibrahim EM, Al-Mulhim FA, Al-Muhanna FA, Al-Amri A: Effect of granulocyte-macrophage colony-stimulating factor on chemotherapy-induced oral mucositis in non-neutropenic cancer patients. Journal of family & community medicine 1998, 5(1):37.

108. Ezzat AA, Ibrahim EM, Raja MA, Al-Sobhi S, Rostom A, Stuart RK: Locally advanced breast cancer in Saudi Arabia: high frequency of stage III in a young population. Medical oncology 1999, 16(2):95-103.

109. Ibrahim E, Ezzat A, Raja M, Rahal M, Ajarim D, Mann B, Baloush A, Stuart R, Bazarbashi S: Primary gastric non-Hodgkin's lymphoma: clinical features, management, and prognosis of 185 patients with diffuse large B-cell lymphoma. Annals of oncology 1999, 10(12):1441-1449.

110. Ibrahim EM, Stuart RK: Evidence-based medicine for the new millennium: Critical appraisal and pragmatic approach. Annals of Saudi medicine 1999, 19(4):295-296.

111. Rahal M, Bazarbashi S, El-Weshi A, Raja M, Pai C, El-Foudeh M, Al-Sayed A, Ezzat A, Ajarim D, Ibrahim E: Salvage chemotherapy for hodgkin's disease - a seven-drug containing regimen with and without stem cell transplant. Eur J Cancer 1999, 35:1337.

112. Al-Qurashi F, Ayas M, Al-Sharif F, Sahovic E, El-Solh H, Al-Mohareb F, Chuadhri N, Al-Omar H, Sarhan M, Stuart R: Outcome of second allogeneic bone marrow transplantation after myeloablative conditioning and its correlation with prognostic factors. In: BLOOD: 2000: AMER SOC HEMATOLOGY 1900 M STREET. NW SUITE 200, WASHINGTON, DC 20036 USA; 2000: 404A-404A.

113. Bazarbashi S, Raja MA, El Sayed A, Ezzat A, Ibrahim E, Kattan S, Kardar A, Peracha A, Lindstedt E, Hanash K: Prospective phase II trial of alternating intravesical Bacillus Calmette-Guerin (BCG) and interferon alpha IIB in the treatment and prevention of superficial transitional cell carcinoma of the urinary bladder: preliminary results. J Surg Oncol 2000, 74(3):181-184.

114. Ezzat A, Ibrahim E, Stuart R, Ajarim D, Bazarbashi S, El-Foudeh M, Rahal M, Al-Sayed A, Berry J: Adding high-dose tamoxifen to CHOP does not influence response or survival in aggressive non-Hodgkin's lymphoma: an interim analysis of a randomized phase III trial. Medical Oncology 2000, 17(1):39-46.

33


115. Ezzat AA, Ibrahim EM, Ajarim DS, Rahal MM, Raja MA, Stuart RK, Tulbah AM, Kandil A, Al-Malik OA, Bazarbashi SM: High complete pathological response in locally advanced breast cancer using paclitaxel and cisplatin. Breast cancer research and treatment 2000, 62(3):237-244.

116. Ibrahim E, Ezzat A, Baloush A, Hussain Z, Mohammed G: Pregnancy-associated breast cancer: a case—control study in a young population with a high-fertility rate. Medical Oncology 2000, 17(4):293-300.

117. Rahal M, Ezzat A, Ibrahim E, Ajarim D, Raja A, Stuart R, Tulbah A, Kandi A, Bazarbashi S: Neoadjuvant High-Dose Sequential Chemotherapy with Adriamycin, Paclitaxel, and Cyclophosphamide Is Feasible and Effective in Poor Prognostic Patients with Locally Advanced Breast Cancer. BREAST CANCER RESEARCH AND TREATMENT 2000, 64(1):261-261.

118. Rahal MM, Ezzat AA, Ibrahim EM, Ajarim DS, Raja A, Stuart RK, Tulbah AM, Kandil A, Bazarbashi SN: Neoadjuvant high-dose sequential chemotherapy with adriamycin (a), paclitaxel (p), and cyclophosphamide (c) is feasible and effective in poor prognostic patients with locally advanced breast cancer (labc). . Breast Cancer Research and Treatment 2000, 64:71.

119. El-Weshi A, Khafaga Y, Allam A, Mosseri V, Ibrahim E, El-Serafi M, El-Badawi S: Neoadjuvant chemotherapy plus conventional radiotherapy or accelerated hyperfractionation in stage III and IV nasopharyngeal carcinoma-a phase II study. Acta Oncologica 2001, 40(5):574-581.

120. Ezzat A, Ibrahim E: High-dose chemotherapy and autologus bone marrow transplantation have no benefit over standard chemotherapy for aggressive non-Hodgkin’s lymphoma. Evidence-Based Oncology 2001, 2:98-100.

121. Ezzat AA, Ibrahim EM, El Weshi AN, Khafaga YM, AlJurf M, Martin JM, Ajarim DS, Bazarbashi SN, Stuart RK, Zucca E: Localized non‐Hodgkin's lymphoma of Waldeyer's ring: Clinical features, management, and prognosis of 130 adult patients. Head & neck 2001, 23(7):547-558.

122. Ibrahim E, Ezzat A, El-Weshi A, Martin J, Khafaga Y, Al Rabih W, Ajarim D, Al-Foudeh M, Zucca E: Primary intestinal diffuse large B-cell non-Hodgkin's lymphoma: clinical features, management, and prognosis of 66 patients. Annals of oncology 2001, 12(1):53-58.

123. Alrajhi AA, Ibrahim EA, De Vol EB, Khairat M, Faris RM, Maguire JH: Fluconazole for the treatment of cutaneous leishmaniasis caused by Leishmania major. The New England journal of medicine 2002, 346(12):891-895.

34


124. Baslaim MM, Al Malik OA, Al-Sobhi SS, Ibrahim E, Ezzat A, Ajarim D, Tulbah A, Chaudhary MA, Sorbris RA: Decreased axillary lymph node retrieval in patients after neoadjuvant chemotherapy. The American journal of surgery 2002, 184(4):299-301.

125. Ibrahim EM, Al-Saad R, Wishi AL: Patient Education-Appraisal of Communication Skills and Patients' Satisfaction in Cross-language Encounters in Oncology Practice. IEEE Transactions on Energy Conversion 2002, 17(4):216-221.

126. Ibrahim EM, Al‐Saad R, Wishi AL, Khafaga YM, Hussainy GE, Nabhan A, Ezzat AA, Ajarim DS, Bazarbashi S, Radwi A: Appraisal of communication skills and patients’ satisfaction in cross‐language encounters in oncology practice. Journal of Cancer Education 2002, 17(4):216-221.

127. Tulbah AM, Ibrahim EM, Ezzat AA, Ajarim DS, Rahal MM, El Weshi AN, Sorbris R: HER-2/Neu overexpression does not predict response to neoadjuvant chemotherapy or prognosticate survival in patients with locally advanced breast cancer. Medical Oncology 2002, 19(1):15-23.

128. Al-Jurf M, Quaideh T, Ezzat A, Ibrahim E, Tabkhi A: Antigen and/or immune-driven immunoproliferative disorders. Annals of Oncology 2003, 14:1595-1606.

129. Ezzat A, Rahal M, Ajarim D, Ibrahim E, Bazarbashi S, Raja M, El Weshi A, El Foudeh M: Dose-dense neoadjuvant sequential chemotherapy in the management of locally advanced breast cancer: A phase II study. Proc Am Soc Clin Oncol 2003, 22:51.

130. Al Shanqeeti A, Seth P, Aslam M, El Solh H, Aljurf M, Al-Qurashi F, Ayas M, Al Sharif F, Ibrahim E, Sahovic E: Second allogeneic bone marrow transplantation after myeloablative conditioning analysis of 43 cases from single institution. Hematology 2004, 9(2):123-129.

131. Ezzat A, Ibrahim E, Ajarim D, Rahal M, Raja M, Tulbah A, Al-Malik O, Al-Shabanah M, Sorbris R: Phase II study of neoadjuvant paclitaxel and cisplatin for operable and locally advanced breast cancer: analysis of 126 patients. Br J Cancer 2004, 90(5):968-974.

132. Ibrahim E, Ezzat A: Failure of the International Prognostic Index to prognosticate outcome in primary gastric DLBC lymphoma. Annals of oncology 2004, 15(5):841-841.

133. Ibrahim E, Fawzy E, Al-Maghraby J, Kanaan H, Radwi A, Bahadur Y: Her-2/neu receptor status and non-small cell lung cancer: is there any prognostic correlation? Kasr-el-Aini Journal of Clinical Oncology and Nuclear Medicine 2005, 1(2).

35


134. Ibrahim EM, Ezzat AA, Rahal MM, Raja MM, Ajarim DS: Adjuvant chemotherapy in 780 patients with early breast cancer: 10-year data from Saudi Arabia. Med Oncol 2005, 22(4):343-352.

135. Elhadd T, AlAmoudi A, AlGhamdi S, Ibrahim E, Elshiekh H: The safety and efficacy of chinese herbal medicine PHS-e2 (Glucoherb) in streptozotocin–induced diabetic wistar rats. Endocrine Abstracts 2006, 11:P276.

136. Ibrahim E, Boulos M: Access to online information by adult Saudi cancer patients. Journal of Health Conusumers of the Internet 2006, 10(4).

137. Ibrahim EM, Boulos MNK: Access to online information by adult Saudi cancer patients. Journal of Consumer Health on the Internet 2006, 10(4):33-43.

138. Ibrahim EM, Stewart RL, Corke K, Blackett AD, Tidy JA, Wells M: Upregulation of CD44 expression by interleukins 1, 4, and 13, transforming growth factor-beta1, estrogen, and progestogen in human cervical adenocarcinoma cell lines. Int J Gynecol Cancer 2006, 16(4):1631-1642.

139. Ibrahim EM, Zeeneldin AA, Al-Gahmi AM, Sallam YA, Fawzi EE, Bahadur YA: Safety and efficacy of cetuximab-chemotherapy combination in Saudi patients with metastatic colorectal cancer. Indian journal of cancer 2007, 44(2):56.

140. Hegazi M, Kumar R, Bitar Z, Ibrahim E: Pancytopenia related to Graves' disease. Annals of Saudi medicine 2008, 28(1):48.

141. Ibrahim E, Bin S, Banjar L, Awadalla S, Abomelha M: Current and future cancer burden in Saudi Arabia: meeting the challenge. Hematology/oncology and stem cell therapy 2008, 1(4):210.

142. Ibrahim EM, Zeeneldin AA, El-Khodary TR, Al-Gahmi AM, Sadiq BMB: Past, present and future of colorectal cancer in the Kingdom of Saudi Arabia. Saudi journal of gastroenterology: official journal of the Saudi Gastroenterology Association 2008, 14(4):178.

143. Ibrahim EM, Zeeneldin AA, Sadiq BB, Ezzat AA: The present and the future of breast cancer burden in the Kingdom of Saudi Arabia. Medical Oncology 2008, 25(4):387-393.

144. Ibrahim E, Al-Gahmi A, Zekri J, Awadalla S, Elkhodary T, Fawzy E, Bahadur Y, Elsayed M, Zeeneldin A, Al-Ahmadi R et al: Preoperative Systemic Therapy in Locally Advanced Breast Cancer: A Single Institution Experience. Ecancermedicalscience 2009, 3 Article Number: 161 DOI.

145. Ibrahim E, Al-Gahmi AM, Zeenelin AA, Zekri JM, Elkhodary TR, Gaballa HE, Fawzy EE, Alzahrani MS: Basal vs. luminal a breast cancer subtypes: a matched case-control study using estrogen receptor, progesterone receptor, and HER-2 as surrogate markers. Medical Oncology 2009, 26(3):372-378.

36


146. Ibrahim E, Al-Gahmi AM, Zeenelin AA, Zekri JM, Elkhodary TR, Gaballa HE, Fawzy EE, El sayed ME, Alzahrani MS: Basal vs. luminal A breast cancer subtypes: a matched case-control study using estrogen receptor, progesterone receptor, and HER-2 as surrogate markers. Med Oncol 2009, 26(3):372-378.

147. Ibrahim E, Bunyan R, Al-Mulhim F, Al-Nabhan A, Ibrahimá R: Chemotherapy with MECOP-B for intermediate-grade and high-grade non-Hodgkin’s lymphoma in Saudi Arabia: clinical results and analysis of prognostic factors. Acta haematologica 2009, 96(3):126-134.

148. Ibrahim EM, Al-Gahmi A, Zekri J, Awadalla S, Elkhodary T, Fawzy E, Bahadur Y, Elsayed M, Zeeneldin A, Al-Ahmadi R: Pre-operative systemic therapy in locally advanced breast cancer: a single institution experience. ecancermedicalscience 2009, 3.

149. Satti M, Al-Sohaibani M, Al-Sowayan S, Al-Quorain A, Ibrahim E: Splenic foam cells: a clinico-pathologic analysis of 92 splenectomized patients. Acta haematologica 2009, 83(1):9-15.

150. Boulos DN, Ghali RR, Ibrahim EM, Boulos MN, Abdelmalik P: An eight-year snapshot of geospatial cancer research (2002-2009): clinico-epidemiological and methodological findings and trends. Med Oncol 2010.

151. Ibrahim E, Zekri J, Abdelrahman H: Adjuvant Platinum-Based Chemotherapy versus Observation in Non-Small Cell Lung Cancer: Meta-analysis of Trials with Intermediate- and Long-Term Follow-up. The Open Lung Cancer Journal 2010, Accepted for Publication.

152. Ibrahim E, Zekri J, Bin Sadiq B: Cetuximab-Based Therapy for Metastatic Colorectal Cancer: A Metaanalysis of the Effect of K-ras Mutations. Inter J Colorectal Disease 2010, Accepted for Publication.

153. Ibrahim EM: Frontline gefitinib in advanced non-small cell lung cancer: meta-analysis of published randomized trials. Annals of thoracic medicine 2010, 5(3):153.

154. IBRAHIM EM, ELKHODARY TR, ZEKRI JM, BAHADUR Y, EL‐SAYED ME, AL‐GAHMI AM, RIZVI SAJ, HASSOUNA AH, FAWZY EE, AWADALLA SS: Prognostic value of lymph node ratio in poor prognosis node‐positive breast cancer patients in Saudi Arabia. Asia‐Pacific Journal of Clinical Oncology 2010, 6(2):130-137.

155. Ibrahim EM, Zekri JM: Folic acid supplementation for the prevention of recurrence of colorectal adenomas: metaanalysis of interventional trials. Medical Oncology 2010, 27(3):915-918.

37


156. Ibrahim EM, Zekri JM, Sadiq BMB: Cetuximab-based therapy for metastatic colorectal cancer: a meta-analysis of the effect of K-ras mutations. Int J Colorectal Dis 2010, 25(6):713-721.

157. Zekri J, Ibrahim E, Sadiq BB, Al-Gahmi A, Zeeneldin A, Elkhodary T, Gaballa H, Fawzy E, Elsayed M, Bahadur Y: A matched group study of triple negative versus HER-2 positive (irrespective of hormonal status) breast cancer: two subtypes with high-risk features and poor outcome. ecancermedicalscience 2010, 4.

158. Zekri JM, Ibrahim E, Al-Gahmi A, Zeeneldin A, Elkhodary T, Gaballa H, Fawzy E, Elsayed M, Bahadur Y, Awadalla S: A matched case-control study of Triple negative vs. HER-2 positive (irrespective of hormonal status) breast cancer: two subtypes with high risk features and poor outcome. The gulf journal of oncology 2010(7):14.

159. Zekri JM, Ibrahim E, Sadiq BB, Al-Gahmi AM, Zeeneldin AA, Elkhodary TR, Gaballa HE, Fawzy EE, Elsayed ME, Bahadur Y: A Matched Group Study of Triple Negative vs. HER-2 Positive (irrespective of hormonal status) Breast Cancer: Two Subtypes with High Risk Features and Poor Outcome. Surgery 2010, 30(75):1.0.

160. Boulos DNK, Ghali RR, Ibrahim EM, Boulos MNK, AbdelMalik P: An eight-year snapshot of geospatial cancer research (2002–2009): clinico-epidemiological and methodological findings and trends. Medical Oncology 2011, 28(4):1145-1162.

161. Ibrahim EM, Abouelkhair KM: Clinical outcome of panitumumab for metastatic colorectal cancer with wild-type KRAS status: a meta-analysis of randomized clinical trials. Medical Oncology 2011, 28(1):310-317.

162. Ibrahim EM, Abouelkhair KM, Al-Masri OA, Chaudry NC, Kazkaz GA: Cetuximab-based therapy is effective in chemotherapy-naive patients with advanced and metastatic non-small-cell lung cancer: a meta-analysis of randomized controlled trials. Lung 2011, 189(3):193-198.

163. Ibrahim EM, Al-Homaidh A: Physical activity and survival after breast cancer diagnosis: meta-analysis of published studies. Medical oncology 2011, 28(3):753-765.

164. Ibrahim EMAIM: Systematic Review: Anti–Epidermal Growth Factor Receptor Treatment Effect Modification by KRAS Mutations in Advanced Colorectal Cancer. Ann Intern Med 2011, 154:37-49.

165. Elsheikh H, Ibrahim E, Al-Ghamdi S, Elhadd T, Al-Malki T: Metabolic efficacy of PHS-E 2 (Glucoherb), a chinese antidiabetic herbal health product, in Streptozotocin-induced diabetic wistar rats. Saudi Journal for Health Sciences 2012, 1(1):9.

38


166. Ibrahim EM, Abouelkhair KM, Kazkaz GA, Elmasri OA, Al-Foheidi M: Risk of second breast cancer in female Hodgkin’s lymphoma survivors: a meta-analysis. BMC Cancer 2012, 12(1):197.

167. Ibrahim EM, Al-Fayea TM, Kazkaz GA: The clinical role of cetuximab in the management of non-small-cell lung cancer. Lung Cancer Management 2012, 1(1):3-5.

168. Ibrahim EM, Kazkaz GA, Abouelkhair KM, Bayer AM, Elmasri OA: Sunitinib adverse events in metastatic renal cell carcinoma: a meta-analysis. International Journal of Clinical Oncology 2012:1-10.

169. Al-Foheidi M, Al-Mansour MM, Ibrahim EM: Breast cancer screening: review of benefits and harms, and recommendations for developing and low-income countries. Medical Oncology 2013, 30(2):1-15.

170. Ibrahim EM, Kazkaz GA, Abouelkhair KM, Al-Mansour MM, Al-Fayea TM, Al-Foheidi M, Bayer AM, Elmasri OA: Increased Risk of Second Lung Cancer in Hodgkin’s Lymphoma Survivors: A Meta-analysis. Lung 2013, 191(1):117-134.

39

Documents

EZZELDIN M Ibrahim - Ego JUNE 2013 (1).doc · Web viewProf. Ezzeldin M Ibrahim Senior Consultant Oncologist Director, Oncology Center of Excellence Chairman, Department of Internal